Forget MannKind Corporation; Here Are 3 Better Biotech Stocks
Although MannKind is launching Afrezza this year, our Motley Fool experts think these three stocks may be better buys.
Why Horizon Pharma PLC Stock Skyrocketed Today
Following a report that hedge funds are buying more shares, Horizon Pharmaceuticals is heading higher ahead of earnings that will be reported later this month.
Has Pfizer Inc. Finally Solved Its Immuno-oncology Problem?
Pfizer has jumped into the promising field of cancer immunotherapy with both feet. Is this effort too little, too late for the pharma giant?